ID   M4A1-M2B9
AC   CVCL_D4AF
DR   DSMZ; ACC-967
DR   EGA; EGAD00001009758
DR   EGA; EGAD00001009759
DR   Wikidata; Q127382727
RX   PubMed=37051743;
CC   Characteristics: Established from a patient-derived xenograft obtained by intrafemoral injection in NOD scid mice (PubMed=37051743).
CC   Doubling time: 56.8 hours (Note=In 20% FCS) (PubMed=37051743); ~48 hours (DSMZ=ACC-967).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=37051743).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=37051743).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1008; BCL9 + HGNC; HGNC:6997; MEF2D; Name(s)=MEF2D-BCL9 (PubMed=37051743).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-967
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 8,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
RX   PubMed=37051743; DOI=10.3324/haematol.2022.281712; PMCID=PMC10542830;
RA   van Outersterp I., Hormann F.M., Hoogkamer A.Q., Boeree A.,
RA   van den Broek S.A., den Boer M.L., Boer J.M.;
RT   "Characterization of a novel MEF2D-BCL9 fusion-positive acute
RT   lymphoblastic leukemia cell line.";
RL   Haematologica 108:2859-2864(2023).
//